Pages that link to "Q29614264"
Jump to navigation
Jump to search
The following pages link to Microbial influences in inflammatory bowel diseases (Q29614264):
Displaying 50 items.
- Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases (Q21090656) (← links)
- Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC) (Q21263046) (← links)
- Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease (Q21560778) (← links)
- Use of antibiotics in the treatment of Crohn's disease (Q22241216) (← links)
- Dietary and nutritional considerations for inflammatory bowel disease (Q22251396) (← links)
- From structure to function: the ecology of host-associated microbial communities (Q24612050) (← links)
- Intestinal microbiota in human health and disease: the impact of probiotics (Q24628739) (← links)
- Toward defining the autoimmune microbiome for type 1 diabetes (Q24629032) (← links)
- Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine (Q24648636) (← links)
- Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery (Q24658549) (← links)
- Use of rifaximin in gastrointestinal and liver diseases (Q26740201) (← links)
- Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease (Q26741037) (← links)
- Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease (Q26741117) (← links)
- The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions (Q26745700) (← links)
- Paneth cell α-defensins and enteric microbiota in health and disease (Q26747303) (← links)
- Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients (Q26750985) (← links)
- Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice (Q26765030) (← links)
- Fecal microbiota transplantation: in perspective (Q26765214) (← links)
- Gut microbiota in autism and mood disorders (Q26772308) (← links)
- How to predict clinical relapse in inflammatory bowel disease patients (Q26774575) (← links)
- Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection (Q26774688) (← links)
- Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology (Q26775404) (← links)
- Effects of Mycotoxins on mucosal microbial infection and related pathogenesis (Q26777059) (← links)
- Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis (Q26781239) (← links)
- Maintaining and Monitoring the Defined Microbiota Status of Gnotobiotic Rodents (Q26795699) (← links)
- Role of the normal gut microbiota (Q26798294) (← links)
- Human breast milk and the gastrointestinal innate immune system (Q26823809) (← links)
- The role of macrophages and dendritic cells in the initiation of inflammation in IBD (Q26827408) (← links)
- The three genetics (nuclear DNA, mitochondrial DNA, and gut microbiome) of longevity in humans considered as metaorganisms (Q26849345) (← links)
- Current status and prospects of intestinal microbiome studies (Q26851992) (← links)
- Non-systemic drugs: a critical review (Q26863371) (← links)
- Fusobacterium and Enterobacteriaceae: important players for CRC? (Q26865094) (← links)
- Current status and future promise of the human microbiome (Q26865656) (← links)
- Gut microbiota and gastrointestinal health: current concepts and future directions (Q26865880) (← links)
- Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility (Q26995672) (← links)
- Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin (Q26998404) (← links)
- Dextran sodium sulphate colitis mouse model: traps and tricks (Q27001084) (← links)
- The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials (Q27001546) (← links)
- Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease (Q27003192) (← links)
- Host-microbe interactions in the gut of Drosophila melanogaster (Q27007557) (← links)
- Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation (Q27011804) (← links)
- Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells (Q27021395) (← links)
- Intestinal barrier in inflammatory bowel disease (Q27023724) (← links)
- Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut (Q27025911) (← links)
- Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis (Q27314835) (← links)
- Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription (Q27334496) (← links)
- RETRACTED: Gut microbiota and pediatric disease. (Q27691431) (← links)
- Effect of barrier microbes on organ-based inflammation (Q27693228) (← links)
- Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models (Q28072332) (← links)
- The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review (Q28078219) (← links)